3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Radiosurgery
114
Temozolomide
104
Bevacizumab
71
Radiotherapy
67
Magnetic Resonance Spectroscopy
67
Carboplatin
29
pembrolizumab
28
Irinotecan
26
Surgical Procedures, Operative
25
Radiation
23
Nivolumab
23
Etoposide
22
Magnetic Resonance Imaging
21
Ipilimumab
21
Erlotinib Hydrochloride
21
Cyclophosphamide
21
Surveys and Questionnaires
19
Aminolevulinic Acid
18
Specimen Handling
16
Pemetrexed
16
Mental Status and Dementia Tests
16
Cisplatin
16
Carmustine
15
Topotecan
14
Trastuzumab
13
Saline Solution
12
Neuropsychological Tests
12
Gefitinib
11
Filgrastim
11
Drug Therapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Brain Neoplasms
×
Patient-Specific Modeling
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn